Patient Centered Primary Care Collaborative

Body Vision Medical Awarded Agreement with Premier, Inc.

Retrieved on:

Tuesday, October 31, 2023

Survival, Premier, Lung cancer, Patient Centered Primary Care Collaborative, Premier, Inc., Health, Artificial intelligence, Hospital, Biopsy, CT, Patient, Diagnosis, Nursing, Medical imaging

CAMPBELL, Calif., Oct. 31, 2023 /PRNewswire/ -- Body Vision Medical, a leader in AI-driven, intraoperative imaging, announced today it was awarded a national "Mobile C-Arms" purchasing agreement with Premier, Inc. for the LungVision system.

Key Points:

CAMPBELL, Calif., Oct. 31, 2023 /PRNewswire/ -- Body Vision Medical, a leader in AI-driven, intraoperative imaging, announced today it was awarded a national "Mobile C-Arms" purchasing agreement with Premier, Inc. for the LungVision system.
Effective December 1, 2023, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Body Vision's LungVision™ AI-powered image-guidance platform for lung nodule biopsy.
"This marks an extraordinary opportunity to expand access to LungVision™ real-time intraoperative imaging to Premier's members for the betterment of their patients."
Body Vision Medical's LungVision™ system uses artificial intelligence (AI) to transform X-ray images from any C-arm into real-time, intraoperative CT scans.

CurePSP Recognizes Three Prominent Medical Institutions for Their Care for PSP, CBD and MSA

Retrieved on:

Thursday, October 5, 2023

PSP, CBD and MSA, which are considered "atypical parkinsonian syndromes," often go underrecognized and underdiagnosed.

Key Points:

PSP, CBD and MSA, which are considered "atypical parkinsonian syndromes," often go underrecognized and underdiagnosed.
Additionally, autonomic dysfunction (e.g., blood pressure regulation, urinary control) is a hallmark feature of MSA, while PSP and CBD can present with cognitive impairment and difficulty expressing words.
"The continued growth of our care network is one impactful way we can work toward improving the standard of care for PSP, CBD and MSA."
"Through becoming a CurePSP Center of Care, our ability to care for our patients will only expand and strengthen," Dr. Brown said.

CHRISTUS Health Awards Nearly $3 Million to 42 Nonprofit Organizations

Retrieved on:

Thursday, September 14, 2023

IRVING, Texas, Sept. 14, 2023 (GLOBE NEWSWIRE) -- CHRISTUS Health is proud to announce awards of nearly $3 million to 42 non-profit organizations, collaboratives and coalitions across Texas, Louisiana, and New Mexico through the CHRISTUS Community Impact Fund (CCIF).

Key Points:

IRVING, Texas, Sept. 14, 2023 (GLOBE NEWSWIRE) -- CHRISTUS Health is proud to announce awards of nearly $3 million to 42 non-profit organizations, collaboratives and coalitions across Texas, Louisiana, and New Mexico through the CHRISTUS Community Impact Fund (CCIF).
More than $18 million has been invested in communities served by CHRISTUS Health.
Selected organizations received the funds for programs that address critical social determinants of health in the communities they serve.
CHRISTUS Good Shepherd Health System, $275,000: Buckner Children and Family Services, East Texas Food Bank, Newgate Mission and Twelve Way Foundation.

Teleflex Awarded National Group Purchasing Agreements with Premier, Inc.

Retrieved on:

Tuesday, July 25, 2023

Teleflex, Emergency medicine, Laryngeal mask airway, TFX, Patient Centered Primary Care Collaborative, Airway management, Hospital, Health, Premier, NYSE, Airline, Pharmaceutical industry, Anesthesia

WAYNE, Pa., July 25, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded three group purchasing agreements with Premier, Inc.

Key Points:

WAYNE, Pa., July 25, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded three group purchasing agreements with Premier, Inc.
Effective August 1st, 2023, the new agreements allow Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for select Teleflex products in the Laryngoscope Systems, Laryngeal Masks Airways, and Disposable Anesthesia Products categories.
Teleflex, through its Rüsch™ and LMA™ products, provides healthcare providers solutions to optimize patient outcomes by offering broad portfolios to meet every day airway needs.
The group purchasing agreements include access to Rüsch™ and Sheridan™ endotracheal tubes, nasal and oral airways, and LMA™ supraglottic devices.

Zingaro, Fidler, Wolfe & Company awarded Executive Recruiting Agreement with Premier, Inc.

Retrieved on:

Monday, July 24, 2023

Consulting, Professional Services, Human Resources, Hospital, Patient Centered Primary Care Collaborative, Premier, Inc.

Zingaro, Fidler, Wolfe & Company has been awarded a national group purchasing agreement for Executive Recruiting services with Premier, Inc. effective January 1, 2023.

Key Points:

Zingaro, Fidler, Wolfe & Company has been awarded a national group purchasing agreement for Executive Recruiting services with Premier, Inc. effective January 1, 2023.
The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Executive Recruiting services.
“Procuring the Premier group purchasing agreement allows Zingaro, Fidler, Wolfe & Company the opportunity to provide the same high-quality executive recruiting services to Premier members that we have provided since 1989,” said Tracy Wolfe, Managing Partner.
With integrated data and analytics, collaboratives, supply chain solutions, and consulting, and other services, Premier enables better care and outcomes at a lower cost.

ARCPOINT LAUNCHES MYARCPOINTLABS TO HELP CLOSE A GROWING GAP WITHIN THE HEALTHCARE SYSTEM BY DELIVERING PREVENTATIVE HEALTHCARE SOLUTIONS TO ALL THOSE WHO WANT THEM

Retrieved on:

Monday, July 10, 2023

MAPL, Insurance, DNA, Primary health care, Health, NACHC, ARC, Patient Centered Primary Care Collaborative, Community, Confusion, National Association, UnitedHealth Group, Family, Pharmaceutical industry, Health insurance, Online shopping

ARCpoint’s President and CEO, John Constantine commented “The US healthcare system is complicated, it can be expensive, and for too many people, it is difficult to access.

Key Points:

ARCpoint’s President and CEO, John Constantine commented “The US healthcare system is complicated, it can be expensive, and for too many people, it is difficult to access.
By combining an easy-to-use consumer mobile platform with intuitive digital marketing and scheduling tools, MAPL will help close a growing gap within the healthcare system by delivering preventative healthcare solutions to all those who want them.
1) United Healthcare is a provider of health benefit programs and a businesses of UnitedHealth Group, which trades on the New York Stock Exchange.
You can view information about the NACHC Closing the Primary Care Gap, including information about the survey methodology, parameters and constraints at https://www .nachc.org/wp-content/uploads/2023/02/Closing-the-Primary-Care-Gap_Full-Report_2023_digital-final.pdf

VERO Biotech's GENOSYL® Delivery System recognized as a "Technological Breakthrough" at Premier, Inc.'s Annual Supplier Innovation Celebration

Retrieved on:

Wednesday, June 14, 2023

Premier, Patient Centered Primary Care Collaborative, DS, Nitric oxide, Hospital, Patient, Health, FDA, Pulmonary hypertension, Regulation of tobacco by the U.S. Food and Drug Administration, Conference, Premier, Inc., Food, Pharmaceutical industry, Vero, Exhibition

ATLANTA, June 14, 2023 /PRNewswire/ -- VERO Biotech Inc., a commercial-stage healthcare business dedicated to neonatal intensive care and the acute care hospital community, today announced that it will be honored during Premier, Inc.'s annual supplier Innovation Celebration at the 2023 Breakthroughs Conference and Exhibition.

Key Points:

VERO Biotech's GENOSYL® Delivery System recognized as a "Technological Breakthrough" by Premier, Inc.
VERO Biotech's GENOSYL® Delivery System (DS) will be recognized as a "Technological Breakthrough."
We are deeply committed to continued innovation so that we may better serve patients, respiratory therapists, and healthcare providers."
GENOSYL DS is the first tankless inhaled nitric oxide delivery system approved by the U.S. Food and Drug Administration (FDA).
This eliminates the need for hospitals to manage large, cumbersome tanks, helps to simplify clinical workflow, and streamlines patient care.

Preparing Physician Leaders for the Future: AAPL, KORN FERRY Release White Paper That Details How Physician Leadership Will Benefit Healthcare Post Pandemic

Retrieved on:

Friday, June 9, 2023

WASHINGTON, June 9, 2023 /PRNewswire/ -- The American Association for Physician Leadership (AAPL) and Korn Ferry today issued a white paper, Preparing Physician Leaders for the Future , which highlights measurable ways that physician leadership benefits healthcare.

Key Points:

WASHINGTON, June 9, 2023 /PRNewswire/ -- The American Association for Physician Leadership (AAPL) and Korn Ferry today issued a white paper, Preparing Physician Leaders for the Future , which highlights measurable ways that physician leadership benefits healthcare.
"Physician leaders are essential to healthcare leadership teams, and their expertise has been embraced by their leadership colleagues in finance, human resources, and other administrative positions.
The importance of their role was underscored during the COVID-19 pandemic, when patients and the public relied foremost on physician leaders for guidance to navigate the crisis," the white paper states.
Non- physician healthcare executives have welcomed physician leaders into their ranks, and top-performing organizations recognize the need for more physician leaders.

RLS Awarded Radiopharmaceutical Products (Distributor) Agreement with Premier, Inc.

Retrieved on:

Monday, June 5, 2023

RLS, Patient Centered Primary Care Collaborative, Radiopharmaceutical, Joint Commission, Hospital, Patient, USP, Health insurance, Nursing

LAKE ZURICH, Ill., June 5, 2023 /PRNewswire/ -- RLS (USA), Inc. (Radioisotope Life Sciences) , the third-largest nuclear medicine pharmacy network in the US, has been awarded a national group purchasing agreement for the distribution of Radiopharmaceutical Products with Premier, Inc , a leading healthcare improvement company headquartered in Charlotte, North Carolina.

Key Points:

LAKE ZURICH, Ill., June 5, 2023 /PRNewswire/ -- RLS (USA), Inc. (Radioisotope Life Sciences) , the third-largest nuclear medicine pharmacy network in the US, has been awarded a national group purchasing agreement for the distribution of Radiopharmaceutical Products with Premier, Inc , a leading healthcare improvement company headquartered in Charlotte, North Carolina.
Effective July 1, 2023, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for radiopharmaceutical compounding and delivery services from RLS.
RLS is a Joint Commission accredited radiopharmacy network with a national footprint and a recognized leader in USP compliance.
Opening our doors to Premier members is critical for RLS as we continue to scale our business and work to optimize patient outcomes."

Teleflex Awarded Agreements with Premier, Inc.

Retrieved on:

Thursday, June 1, 2023

Infection, Multisourcing, CLABSI, CVC, Gram-negative bacteria, TFX, Patient Centered Primary Care Collaborative, Fungus, Thrombosis, Hospital, Patient, Risk, Central venous catheter, Premier, NYSE, Birth control, Teleflex

WAYNE, Pa., June 01, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded two group purchasing agreements with Premier, Inc.

Key Points:

WAYNE, Pa., June 01, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded two group purchasing agreements with Premier, Inc.
Effective July 1st, 2023, the new agreements allow Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Teleflex’s Central Venous and Arterial Vascular Access products.
Premier has awarded Teleflex a national agreement for Hemodynamic Monitoring Products and Accessories, a national agreement for Central Venous Access, a Sole Source for AscenDrive Central Venous Access, and a Sole Source for SURPASS Central Venous Access.
“Teleflex strives to deliver vascular access products that are designed to benefit both clinicians and patients, while helping to protect against vascular access related complications like infection and thrombosis,” said Lisa Kudlacz, President and General Manager, Teleflex Vascular.